Gemina Laboratories Ltd. (id:480 GLAB)
0.900 CAD
Opening hours: 09:30 - 16:00 (Eastern Standard Time: 11/23/2024 3:09:54 PM)
Exchange closed, opens in 1 day 18 hours
25.00 CAD (25.00%)
80.00 CAD (80.00%)
168.66 CAD (168.66%)
100.00 CAD (100.00%)
125.00 CAD (125.00%)
80.00 CAD (80.00%)
About Gemina Laboratories Ltd.
Market Capitalization 42.51M
Gemina Laboratories Ltd., a biotechnology company, engages in the research, development, and commercialization of in-vitro diagnostics in Canada. The company develops LEGIO X COVID-19, a COVID-19 rapid antigen test; and LEGIO X Influenza AB, an influenza AB multiplex lateral flow test. It is developing respiratory syncytial virus and tuberculosis. Gemina Laboratories Ltd. was incorporated in 2017 and is headquartered in Burnaby, Canada.
| Headquarters (address) |
3600 Gilmore Way Burnaby V5G 4W8 BC Canada |
| Phone | |
| Website | https://www.geminalabs.com |
| Employees | 6 |
| Sector | Healthcare |
| Industry | Biotechnology |
| Ticker | GLAB |
| Exchange | Canadian Securities Exchange |
| Currency | CAD |
| 52 week range | 0.280 - 0.720 |
| Market Capitalization | 42.51M |
| P/E trailing | -10.29 |
| Price/Book | -19.94 |
| Beta | 0.095 |
| EPS | -0.040 |
| EPS Canada (ID:82, base:722) | 1.84 |